Press Releases | DEA.gov
Pasar al contenido principal
U.S. flag

Un sitio oficial del Gobierno de Estados Unidos

Así es como usted puede verificarlo

Dot gov
Los sitios web oficiales usan .gov
Un sitio web .gov pertenece a una organización oficial del Gobierno de Estados Unidos.
Https

Los sitios web seguros .gov usan HTTPS
Un candado ( Candado Un candado cerrado ) o https:// significa que usted se conectó de forma segura a un sitio web .gov. Comparta información sensible sólo en sitios web oficiales y seguros.

  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
      • Operational Divisions
    • DEA Museum
    • Wall of Honor
    • Contáctenos
      • Submit a Tip
      • Extortion Scam
      • Public Affairs
      • Social Media Directory
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
      • Fee Waiver
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
      • Human Trafficking Prevention

United States Drug Enforcement Administration

  • Recibir Actualizaciones
  • Scam Alert
  • Menú Completo
  • English
  • Español

Main Menu

Explore DEA
  • Quiénes somos
    • Sobre la DEA
    • Mission
    • Leadership
    • Nuestra historia
    • Divisiones Nacionales
    • DEA Museum
    • Wall of Honor
    • Contáctenos
  • Recursos
    • Cartels
    • Illegal Online Pharmacies
    • OD Justice
    • Fentanyl Supply Chain
    • Pill Press Resources
    • Recovery Resources
    • Together for Families
    • Ley de Libertad de Información
    • Publications
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas

Press Releases

Advanced Search

Enter Keywords Below

Filter Results

Select To Narrow Search Results

Year

  • 2026 (50)
  • 2025 (71)
  • 2024 (67)
  • 2023 (106)
  • 2022 (92)
  • 2021 (76)
  • 2020 (36)
  • 2019 (19)
  • 2018 (4)
  • 2017 (1)

Subject

  • Drug Trafficking (4449)
  • Synthetic drugs (1227)
  • Guns/Weapons (1105)
  • OCDETF/Task Force (830)
  • Arrests/Convictions - Major (730)
  • Fake Pills (721)
  • Guilty Plea (589)
  • Seizures (Drugs/Property) (527)
  • Prescription Drugs (398)
  • Overdose (339)
  • Major Law Enforcement Operation (301)
  • Task Forces/Task Force Officers (274)
  • Pharmaceuticals/Pharmacists/Physicians (244)
  • Money Laundering (231)
  • Gangs (210)
  • Outreach/Drug Prevention (199)
  • Fentanyl Awareness (197)
  • One Pill Can Kill (128)
  • HIDTA (110)
  • Fentanyl Free America (89)
  • Press Conferences (74)
  • Counterfeit Pills (65)
  • Extraditions (57)
  • Prevention/Education - DEA websites GSAD, JTT etc (57)
  • Narcoterrorism (56)
  • Public and Media Affairs - also see Congressional Affairs (53)
  • Asset Forfeiture (31)
  • Dark Web- Internet Trafficking (31)
  • International/Foreign Operations (30)
  • Red Ribbon (28)
  • Campaigns (24)
  • Other (16)
  • Congressional Affairs (15)
  • Terrorism (15)
  • Cartel (11)
  • Critical Incident (10)
  • Intergovernmental Affairs (9)
  • Intelligence Division - Intelligence Products (6)
  • Scam Calls (5)
  • Museum and Visitors Center (3)
  • El Paso Intelligence Center (2)
  • Recruitment/Office of Training/Graduations (2)
  • Diversion Division (279)
  • Take Back Day (268)

Drug Name

  • Opioids (46)
  • Oxycodone (46)
  • Fentanyl (36)
  • Hydromorphone (18)
  • Benzodiazepines (11)
  • Synthetic Opioids (11)
  • Methamphetamine (7)
  • Morphine (7)
  • Amphetamines (5)
  • Cocaine (3)
  • Heroin (3)
  • Methadone (3)
  • Steroids (3)
  • Marijuana (Cannabis) (2)
  • Barbiturates (1)
  • GHB (1)
  • Ketamine (1)
  • Marijuana Concentrates (1)

Field Division

  • Atlanta (25)
  • Chicago (26)
  • Dallas (10)
  • Detroit (2)
  • El Paso (22)
  • Houston (21)
  • Los Angeles (7)
  • Louisville (20)
  • Miami (21)
  • New England (39)
  • New Jersey (27)
  • New Orleans (18)
  • New York (34)
  • Omaha (26)
  • Philadelphia (8)
  • Phoenix (19)
  • Rocky Mountain (17)
  • San Diego (12)
  • San Francisco (13)
  • Seattle (52)
  • Sede (37)
  • St. Louis (24)
  • Washington, DC (41)
Clear All Results
522 Results - Showing 481 to 490
PRESS RELEASE

DEA Announces 19th National Prescription Drug Take Back Day

OMAHA, Neb.— The Drug Enforcement Administration (DEA) is holding its 19 th National Prescription Drug Take Back Day Saturday, October 24, at multiple locations across the country including more than 200 sites within the five state Omaha Division comprised of Iowa, Minnesota, Nebraska, North Dakota and South Dakota. The annual...
PRESS RELEASE

City of Chicago skyline lit red in support of Red Ribbon Week and DEA’s 19th National Prescription Drug Take Back Day on October 24, 2020

CHICAGO – Robert J. Bell, Special Agent in Charge (SAC) of the Drug Enforcement Administration (DEA) Chicago Division, announces the Red Ribbon Celebration during the week of October 23-31, which coincides with DEA’s 19 th National Prescription Drug Take Back Day on October 24, 2020. Red Ribbon Week raises awareness...
PRESS RELEASE

DEA announces 19th National Prescription Drug Take Back Day

BOSTON – DEA is holding its 19th National Prescription Drug Take Back Day on Saturday, Oct. 24 at locations across the country. The nationwide event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse...
PRESS RELEASE

DEA announces 19th National Prescription Drug Take Back Day

WASHINGTON – DEA is holding its 19th National Prescription Drug Take Back Day on Saturday, Oct. 24 at locations across the country. The nationwide event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse...
PRESS RELEASE

DEA announces 19th National Prescription Drug Take Back Day

HOUSTON – DEA is holding its 19th National Prescription Drug Take Back Day on Saturday, Oct. 24 at locations across the country. The nationwide event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse...
PRESS RELEASE

DEA announces 19th National Prescription Drug Take Back Day

WASHINGTON – DEA is holding its 19th National Prescription Drug Take Back Day on Saturday, Oct. 24 at locations across the country. The nationwide event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential for abuse...
PRESS RELEASE

DEA announces 19th National Prescription Drug Take Back Day

NEW YORK CITY – DEA is holding its 19th National Prescription Drug Take Back Day on Saturday, Oct. 24 at locations across the country. The nationwide event aims to provide a safe, convenient, and responsible means of disposing of prescription drugs, while also educating the general public about the potential...
PRESS RELEASE

DEA Implements Ecommerce Outreach Program to Combat Counterfeit Drug Production

WASHINGTON – The U.S. Drug Enforcement Administration has developed an e-commerce outreach program aimed at reducing the availability of dangerous, often deadly, counterfeit prescription drugs in the United States. This DEA-led initiative focuses on educating online retailers about the sale of pill presses and components used in the production of...
PRESS RELEASE

DEA St. Louis Division launches website for community resources

ST. LOUIS – Unintended consequences of social distancing and isolation throughout the COVID-19 pandemic can include increased substance use, experimentation and even relapse for those in treatment and recovery. To help people find support facilities, the Drug Enforcement Administration St. Louis Division, along with community partners, has launched a website...
PRESS RELEASE

Omnicare Inc. agrees to pay more than $15 million to resolve allegations it improperly dispensed narcotics at long-term care facilities

WASHINGTON – Omnicare Inc., a subsidiary of CVS Health and a leading provider of pharmacy services to long-term care facilities, has agreed to pay the United States a $15.3 million civil penalty to resolve allegations that it violated federal law by allowing opioids and other controlled substances to be dispensed...

Paginación

  • Primera página «
  • Anterior
  • Página 45
  • Página 46
  • Página 47
  • Página 48
  • Current page 49
  • Página 50
  • Página 51
  • Página 52
  • Página 53
  • Siguiente
  • Última página »
  • Quienes Somos
    • Sobre
    • Contáctenos
    • Museo DEA
  • Recursos
    • Ley de Libertad de Información (FOIA)
    • Publicaciones
    • Galerías Multimedia
    • Programa de Asistencia a Testigos para Víctimas
  • Políticas
    • Accesibilidad, Complementos y Política
    • Políticas Legales y Descargos de Responsabilidad
    • Antidiscriminación y Represalias Acto
    • Política de Privacidad
    • Política de Igualdad de Oportunidades en el Empleo del U.S. DOJ
    • USA.gov
    • Protección de Denunciantes
    • Your Rights as a Federal Employee

United States Drug Enforcement Administration

DEA.gov is an official site of the U.S. Department of Justice
Facebook X LinkedIn Instagram

DEA Contact Center

(202) 307-1000
Contact the Webmaster